Neurosurgery Market, By Device Type (Neurosurgery Software, Radiosurgery Systems, and Neuro Interventional Devices), By Surgery Type (Spine Surgery, and Functional Neurosurgery), By Application (Brain Tumors, Cortical Mapping, Parkinson's disease, and Chronic Pain), By End-User (Ambulatory Surgical Centers, Neurosurgery Centers, Hospitals, Research Centers, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

• Terumo Corporation
• Clarus Medical LLC.
• Medtronic
• Integra LifeSciences
• Resonetics
• Boston Scientific Corporation
• Penumbra Inc.
• Stryker
• Braun SE.
• Adeor Medical AG.  

Recent News:

• Anuncia Medical Effectively Introduced a Second Generation Device to Treat Hydrocephalus at Several Top Neurosurgical Centers in the US in July 2023. Providing improved access to potentially life-saving treatment for the 30 million individuals with hydrocephalus has given neurosurgeons both domestically and internationally a new approach to lessen the impacts of this neurological condition.
• Following regulatory clearance in the US, Canada, and Australia, Omniscient Neurotechnology introduced the Quicktome Brain Mapping Platform for Neurosurgery in July 2021. Regular neurosurgery planning incorporates the "connectomics" science—the study of the connections between brain regions—through the use of the Quicktome program. Crucially, Quicktome reduces surgical uncertainty and improves decision-making for neurosurgeons by seeing the networks that underlie complex functions like language, movement, and thought.